|
Market Closed -
Nasdaq
16:00:00 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.2831 USD | -2.81% |
|
-14.29% | -90.10% |
| 09-16 | Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma | FI |
| 09-15 | Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 46.68B | |||||
| 44.42B | |||||
| 41.58B | |||||
| 41.32B | - | - | - | - | - |
| 30.14B |
Select your edition
All financial news and data tailored to specific country editions
